Where the Money Goes

Fred Hutch counts on Obliteride fundraising — and our sponsors ensure that 100% of every dollar you raise helps us advance cancer prevention, detection, treatment, and cures. In the last 10 years, we’ve fueled new approaches for breast, colon, pancreatic and prostate cancer; breakthroughs in data science; community partnerships that improve health; novel therapies that retrain the body’s immune cells to attack cancers; and powerful insights into diet, genetics, environmental factors, and cancer risk.

A photo of the I Obliteride for wall

Designate Your Fundraising

Every Obliterider can direct their support to the area of our work that is most meaningful to them, including a specific disease area, program, faculty member, or clinician. Every dollar your community donates to your Obliteride fundraising effort (100%!) will support that work.

About Fred Hutch

Fred Hutchinson Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.

Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services and has network affiliations with hospitals in four states. Fred Hutch also serves as UW Medicine’s cancer program.

Fred Hutchinson Cancer Center is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. Our relationship allows for enhanced care coordination between a top-ranked cancer center and a leading integrated health system and accelerates the latest scientific breakthroughs in cancer and other life-threatening diseases.  

Fred Hutch is proud to raise funds that fuel the adult oncology program on behalf of both Fred Hutch and UW Medicine.

UW Medicine logo

Obliteride + Fred Hutch = Advances That Improve and Save Lives

Meet the experts we supported in 2022. All have appointments with Fred Hutchinson Cancer Center and/or UW Medicine. To learn more about their work, simply click on the link.

Richard Adeyemi, DVM, PhD

Richard Adeyemi, DVM, PhD

Learning how cells fix their broken DNA to understand cancer origins and inform new therapies.

Daniel Blanco-Melo, PhD

Daniel Blanco-Melo, PhD

Understanding our immune response to new and evolving viruses to improve treatments for current and emerging threats.

Marie Bleakley, MD, PhD, MMSC

Marie Bleakley, MD, PhD, MMSC

Developing therapies that optimize the cancer-fighting power of immune T cells while reducing side effects.

Susan Bullman, PhD

Susan Bullman, PhD

Studying how a type of bacteria leads to aggressive colorectal cancer to better prevent and treat it.

Burcu Darst, PhD

Burcu F. Darst, PhD

Improving screening by identifying genetic and other risk factors for prostate cancer in diverse populations.

Scott Nicolas Furlan, MD

Scott Nicolas Furlan, MD

Learning how immune T cells behave during and after treatment to improve immune-based therapies for children.

George Georges, MD

George Georges, MD

Refining blood stem cell transplantation and testing it to treat severe autoimmune diseases.

Leslie Goo, PhD, MPH

Leslie Goo, PhD, MPH

Researching mosquito- and tick-borne flaviviruses, including dengue and Zika, that threaten people worldwide.

Michael C. Haffner, MD, PhD

Michael C. Haffner, MD, PhD

Linking cellular changes to different prostate tumor pathologies to enhance diagnosis.

Aakanksha Singhvi, PhD

Aakanksha Singhvi, PhD

Illuminating the role of glia, which form one-half of our brain cells, in Alzheimer’s and autism.

Nasa Sinnott-Armstrong, PhD

Nasa Sinnott-Armstrong, PhD

Distilling complex genetic and environmental factors to better predict disease risk.

Christina M. Termini, MM, PhD

Christina M. Termini, MM, PhD

Uncovering how blood stem cells repopulate the bone marrow after radiation and transplant.

Masumi Ueda Oshima, MD, MA

Masumi Ueda Oshima, MD, MA

Improving stem cell transplantation and follow-up to catch relapse early. 

Joshua Veatch, MD, PhD

Joshua Veatch, MD, PhD

Designing new immunotherapies that harness immune T cells to fight lung and skin cancers.

Bo Zhang, PhD

Bo Zhang, PhD

Harmonizing medical records and study data to recommend changes in disease diagnosis and public health measures. 

Diversity, Equity & Inclusion

Fred Hutch’s Commitment to Diversity

Lifesaving research demands more than innovation and dedication. It requires curiosity, creativity, and fresh and varied perspectives. That’s why diversity is a core Fred Hutch value that is integral to our work.

Land Acknowledgment

Fred Hutchinson Cancer Center acknowledges the Coast Salish peoples of this land, the land which touches the shared waters of all tribes and bands within the Duwamish, Puyallup, Suquamish, Tulalip and Muckleshoot nations.

Obliteride Is for Everyone!

Take action to help cure cancer faster!